A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Phase 1 results support proceeding to Phase 2 in patients with post-bariatric hypoglycemia (PBH), which is expected to begin in 2H 2025 Phase 1 trial in healthy volunteers showed MBX 1416 was generall ...

Dual- and triple-agonist GLP-1s appear to achieve greater weight loss in an overview of clinical trials of approved and ...

In the MAD cohort, MBX 1416 appeared to increase GLP-1 within 60 minutes of a mixed meal tolerance test, suggesting a ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

The startup is developing macrocyles, which share strengths of both small molecules and biologics, as oral medicines against ...

Researchers at IIT Guwahati and Bose Institute, Kolkata, have created an advanced injectable hydrogel for localized cancer ...

A research team has developed an innovative injectable adhesive hydrogel for bone regeneration. This hydrogel utilizes ...

IIT-G and Bose Institute develop advanced injectable hydrogel for precise cancer treatment, minimizing side effects on ...

In preclinical trials on a murine model of breast cancer, the hydrogel showcased remarkable efficacy, the scientists said.

Researchers have developed an injectable adhesive hydrogel for bone regeneration that uses light for cross-linking.

The developed hydrogel-based therapy delivers anti-cancer drugs directly to tumor sites and after completion of the ongoing ...